Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Econ Theory ; : 1-44, 2022 Jul 23.
Artigo em Inglês | MEDLINE | ID: mdl-35909496

RESUMO

We analyze the relation between individuals' risk aversion and their willingness to expose themselves to infection when faced with an asymptomatic infectious disease. We show that in a high prevalence environment, increasing individuals' risk aversion increases their propensity to engage in transmissive behavior. The reason for this result is that as risk aversion increases, exposure which leads to infection with certainty becomes relatively more attractive than the uncertain payoffs from protected behavior. We provide evidence from a laboratory experiment which is consistent with our theoretical findings.

2.
J Econ Theory ; 204: 105501, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-35702334

RESUMO

This paper considers a susceptible-infected-recovered type model of infectious diseases, such as COVID-19 or swine flu, in which costly treatment or vaccination confers immunity on recovered individuals. Once immune, individuals indirectly protect the remaining susceptibles, who benefit from a measure of herd immunity. Treatment and vaccination directly induce such herd immunity, which builds up over time. Optimal treatment is shown to involve intervention at early stages of the epidemic, while optimal vaccination may defer intervention to intermediate stages. Thus, while treatment and vaccination have superficial similarities, their effects and desirability at different stages of the epidemic are different. Equilibrium vaccination is qualitatively similar to socially optimal vaccination, while equilibrium treatment differs in nature from socially optimal treatment. The optimal policies are compared to traditional non-economic public health interventions which rely on herd immunity thresholds.

3.
Epidemics ; 39: 100585, 2022 06.
Artigo em Inglês | MEDLINE | ID: mdl-35636312

RESUMO

COVID-19 has shown that the consequences of a pandemic are wider-reaching than cases and deaths. Morbidity and mortality are important direct costs, but infectious diseases generate other direct and indirect benefits and costs as the economy responds to these shocks: some people lose, others gain and people modify their behaviours in ways that redistribute these benefits and costs. These additional effects feedback on health outcomes to create a complicated interdependent system of health and non-health outcomes. As a result, interventions primarily intended to reduce the burden of disease can have wider societal and economic effects and more complicated and unintended, but possibly not anticipable, system-level influences on the epidemiological dynamics themselves. Capturing these effects requires a systems approach that encompasses more direct health outcomes. Towards this end, in this article we discuss the importance of integrating epidemiology and economic models, setting out the key challenges which such a merging of epidemiology and economics presents. We conclude that understanding people's behaviour in the context of interventions is key to developing a more complete and integrated economic-epidemiological approach; and a wider perspective on the benefits and costs of interventions (and who these fall upon) will help society better understand how to respond to future pandemics.


Assuntos
COVID-19 , Doenças Transmissíveis Emergentes , COVID-19/epidemiologia , Doenças Transmissíveis Emergentes/epidemiologia , Análise Custo-Benefício , Humanos , Pandemias , Políticas
4.
J Theor Biol ; 363: 105-17, 2014 Dec 21.
Artigo em Inglês | MEDLINE | ID: mdl-25111844

RESUMO

The market for vaccinations is widely believed to be characterized by market failures, because individuals do not internalize the positive externalities that their vaccination decisions may confer on other individuals. Francis (1997) provided a set of assumptions under which the equilibrium vaccination pattern is socially optimal. We show that his conditions are not necessary for the welfare theorem to hold but that in general, the market yields inefficiently low vaccination uptake. Equilibrium non-optimality may obtain if (i) agents can recover from infection, (ii) vaccines are imperfect, (iii) individuals are ex ante heterogeneous, (iv) vaccination timing is inflexible or (v) the planning horizon is finite. Apart from the case with heterogeneity, inefficiencies result from the presence of strategic interaction.


Assuntos
Epidemias/prevenção & controle , Modelos Econômicos , Vacinação/economia , Epidemias/economia , Planejamento em Saúde , Humanos , Fatores de Tempo , Vacinação/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...